ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
2019 · Journal of Crohn s and Colitis · 1,315 citations
https://doi.org/10.1093/ecco-jcc/jjz180
P
Peter Bossuyt
Imelda Hospital(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
481
Papers
16.0K
Citations
60
h-index
173
i10-index
Peter Bossuyt is an academic researcher from Imelda Hospital. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 60, co-authored 409 publications.
ORCID: 0000-0003-4027-7365Papers by this author
worksECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
2019 · Journal of Crohn s and Colitis · 1,095 citations
https://doi.org/10.1093/ecco-jcc/jjz187
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017 · The Lancet · 883 citations
https://doi.org/10.1016/s0140-6736(17)32641-7
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 · Journal of Crohn s and Colitis · 796 citations
https://doi.org/10.1016/j.crohns.2013.09.016
The Clinical Meaning of Rankin ‘Handicap’ Grades After Stroke
1995 · Stroke · 451 citations
https://doi.org/10.1161/01.str.26.11.2027
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
2022 · The Lancet · 369 citations
https://doi.org/10.1016/s0140-6736(22)00467-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat